Maurizio Rossini

Prevalence and determinants of state and trait anxiety in inflammatory rheumatic diseases.

Journal: Journal of psychosomatic research

Published: June 11, 2026

Response to: Letter to the editor regarding: Real‑world rebound pattern of serum collagen type I C‑telopeptide after denosumab discontinuation and zoledronate rescue in postmenopausal osteoporosis and cancer treatment‑induced bone loss.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: May 01, 2026

GRAPPA 2025 Annual Meeting: Advances in Psoriatic Disease Research From Pilot Grant Awardees.

Journal: The Journal of rheumatology

Published: April 13, 2026

Long-term effects of denosumab: a 10-year single-center retrospective study.

Journal: Archives of osteoporosis

Published: March 23, 2026

Response to: Letter comments on: Radiofrequency Echographic Multi Spectrometry (REMS) for the evaluation of bone health in systemic lupus erythematosus (SLE).

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: February 12, 2026

Romosozumab does not improve volumetric bone mineral density at distal radius but is associated with early changes in bone strength: a prospective study.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: January 18, 2026

Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohort.

Journal: Lupus science & medicine

Published: December 18, 2025

The impact of vertebral fractures on pulmonary function tests in patients with interstitial lung disease: a cross-sectional study.

Journal: Respiratory research

Published: December 13, 2025

The impact of vertebral fractures on pulmonary function tests in patients with interstitial lung disease: a cross-sectional study.

Journal: Respiratory research

Published: December 13, 2025

Real-world rebound pattern of serum collagen type I C-telopeptide after denosumab discontinuation and zoledronate rescue in postmenopausal osteoporosis and cancer treatment-induced bone loss.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: November 17, 2025

Prevalence and determinants of state and trait anxiety in inflammatory rheumatic diseases.

Prevalence and determinants of state and trait anxiety in inflammatory rheumatic diseases.

Response to: Letter to the editor regarding: Real‑world rebound pattern of serum collagen type I C‑telopeptide after denosumab discontinuation and zoledronate rescue in postmenopausal osteoporosis and cancer treatment‑induced bone loss.

Response to: Letter to the editor regarding: Real‑world rebound pattern of serum collagen type I C‑telopeptide after denosumab discontinuation and zoledronate rescue in postmenopausal osteoporosis and cancer treatment‑induced bone loss.

GRAPPA 2025 Annual Meeting: Advances in Psoriatic Disease Research From Pilot Grant Awardees.

GRAPPA 2025 Annual Meeting: Advances in Psoriatic Disease Research From Pilot Grant Awardees.

Long-term effects of denosumab: a 10-year single-center retrospective study.

Long-term effects of denosumab: a 10-year single-center retrospective study.

Response to: Letter comments on: Radiofrequency Echographic Multi Spectrometry (REMS) for the evaluation of bone health in systemic lupus erythematosus (SLE).

Response to: Letter comments on: Radiofrequency Echographic Multi Spectrometry (REMS) for the evaluation of bone health in systemic lupus erythematosus (SLE).

Romosozumab does not improve volumetric bone mineral density at distal radius but is associated with early changes in bone strength: a prospective study.

Romosozumab does not improve volumetric bone mineral density at distal radius but is associated with early changes in bone strength: a prospective study.

Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohort.

Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohort.

The impact of vertebral fractures on pulmonary function tests in patients with interstitial lung disease: a cross-sectional study.

The impact of vertebral fractures on pulmonary function tests in patients with interstitial lung disease: a cross-sectional study.

The impact of vertebral fractures on pulmonary function tests in patients with interstitial lung disease: a cross-sectional study.

The impact of vertebral fractures on pulmonary function tests in patients with interstitial lung disease: a cross-sectional study.

Real-world clinical experience with upadacitinib in a cohort of Italian patients with axial spondyloarthritis.

Real-world clinical experience with upadacitinib in a cohort of Italian patients with axial spondyloarthritis.

Fracture risk tools performance and potential use in systemic lupus erythematosus.

Fracture risk tools performance and potential use in systemic lupus erythematosus.

Real-world rebound pattern of serum collagen type I C-telopeptide after denosumab discontinuation and zoledronate rescue in postmenopausal osteoporosis and cancer treatment-induced bone loss.

Real-world rebound pattern of serum collagen type I C-telopeptide after denosumab discontinuation and zoledronate rescue in postmenopausal osteoporosis and cancer treatment-induced bone loss.